key: cord-0891673-0i3136dc
authors: Chong, Chia Yin; Kam, Kai-Qian; Li, Jiahui; Maiwald, Matthias; Loo, Liat Hui; Nadua, Karen Donceras; Tan, Natalie Woon Hui; Yung, Chee Fu; Thoon, Koh Cheng
title: Saliva is not a useful diagnostic specimen in children with Coronavirus Disease 2019
date: 2020-09-14
journal: Clin Infect Dis
DOI: 10.1093/cid/ciaa1376
sha: b46a4a4f123337a48297f63c7085880c749f2c25
doc_id: 891673
cord_uid: 0i3136dc

nan

M a n u s c r i p t

Saliva specimens have shown promise for diagnosing COVID-19 in adults, with a sensitivity of 50.5-96% [1] [2] [3] [4] [5] [6] [7] [8] . However, in children, the utility of saliva specimens is uncertain; thus, we compared saliva to nasopharyngeal (NP) swabs for diagnosing COVID-19 in children.

COVID-19-infected children admitted from 22 June-22 July 2020 had paired NP and saliva specimens tested using a real-time reverse transcription (rRT)-PCR assay for the E gene of SARS-CoV-2 [9].

After abstaining from food and drink for ≥0.5 hour, saliva (minimum 0.5 ml) was collected by patients spitting into a sterile container or by nurses who syringed saliva from inside the mouth of children who were unable to spit.

Cycle threshold (Ct) values of specimens were recorded according to the day of illness (onset of symptoms) for symptomatic patients or day of diagnosis for asymptomatic patients. We grouped days into day 1-3, 4-7, 8-10 and 11-15 for analysis. The Ct cut-off for undetectable virus was 45. Saliva c c e p t e d M a n u s c r i p t on day 11-15. Saliva PCR became negative on mean day 9±3.7 (IQR 6-11); the mean corresponding NP Ct was 31.0±6.0 (IQR 28. 8-33.3) .Young children <5 years (n=5) had lower mean NP Ct when saliva was negative compared to older children ≥5 years old (n=13) (27±6.8 vs 33.3±4.2, p=0.037).

Males were more likely to be asymptomatic (90%, 9/10 vs 37.5%, 3/8, p=0.043) and had higher saliva Ct on day 1-3 (29.2±5.6 vs 22.2±6.4, p=0.045) compared to females. When saliva PCR was negative, males also had higher NP Ct compared to females (33.5±4.8 vs 28.0±6.1, p=0.048). There were no age or Ct differences between symptomatic and asymptomatic patients.

Our study's limitation was 7 out of 55 (12.7%) paired samples had a delayed (3-28 hours) first saliva collection while awaiting NP confirmation of COVID-19.

In conclusion, saliva is not a useful specimen for diagnosing COVID-19 in children. The peak saliva sensitivity was only 52.9% compared to NP swabs. Our previous buccal swab study had a peak sensitivity of 71.4% [10].

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: An observational cohort study

Consistent detection of 2019 novel coronavirus in saliva

Saliva is a reliable tool to detect SARS-CoV-2

Evaluating the use of posterior oropharyngeal saliva in a pointof-care assay for the detection of SARS-CoV-2

Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study

Saliva is more sensitive for SARS-Cov-2 detection in COVID-19 patients than nasopharyngeal swabs

Clinical evaluation of self-collected saliva by RT-qPCR, direct RT-qPCR, RT-LAMP, and a rapid antigen test to diagnose COVID-19

Saliva as an alternate specimen source for detection of SARS-CoV-2 in symptomatic patients using Cepheid Xpert Xpress SARS-CoV-2

A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t